Description: Global giants are clashing in the South America Minimally Invasive Surgery Devices Market, spurring local innovations and market consolidation.

As October 2025 progresses, the South America Minimally Invasive Surgery Devices Market, from USD 3.56 billion in 2024 to USD 5.72 billion by 2035 at 4.41% CAGR, is marked by fierce competitions. Intuitive Surgical holds 18% share with its da Vinci systems in Brazilian hospitals, while Johnson & Johnson's Ethicon counters with cost-competitive laparoscopic lines in Argentina. The rest of South America sees Boston Scientific gaining ground in visualization tech, amid a 12% regional procedure increase driven by chronic care demands.

Segmentation by application shows cardiothoracic leading at 20% for heart valve repairs, with robotic systems excelling in precision. End-users favor ASCs for 28% of general surgeries, emphasizing portable access devices. Product-wise, endoscopes and instruments dominate, supporting diverse needs from gynecological to orthopedic.

Fueling these rivalries, the competitive landscape evolved via Abbott Laboratories' 2023 expansions into urological tools, now prevalent in Santiago. MediStare and Cook Medical are localizing production to evade tariffs, addressing reimbursement hurdles. Opportunities in mergers could consolidate 30% share, enhancing supply chains. This intensity not only lowers prices but elevates standards.

Cross-border alliances will sharpen competitive edges.

#medtechrivalries #surgicalcompetition #devicesmarket #latinamerica #industryleaders